HOPE-MeVO · Intravenous Recombinant Human Prourokinase for Acute Medium Vessel Occlusion 4.5-24 Hours After Ischemic Stroke
Recruitment opened
Also in this update: Start date changed from estimate of Sep 6, 2026 to Oct 6, 2026
The First Affiliated Hospital of Anhui Medical UniversityPhase 3 NCT07776873 Registry history of NCT07776873 on ClinicalTrials.gov (opens the registry)